Semaglutide Reduces Epilepsy Risk in Diabetes Patients
A major study reveals GLP-1 drugs like Ozempic and Wegovy may protect brain health, slashing epilepsy risk for millions with type 2 diabetes. Discover the neurological benefits.
Category : Pharmaceuticals
FDA OKs Libido Pill for Post-Menopausal Women Over 65
US health officials approve Addyi for women over 65 with low sexual desire. Learn about the decade-long journey, side effects, and the debate surrounding female sexual health treatments.
Medications You Shouldn't Take With Coffee
Your morning coffee can reduce the effectiveness of common drugs or increase side effects. Learn which five types of medication to be cautious with and how to stay safe.
Weight loss jab users warned of Christmas vomiting risk
A clinical pharmacist warns festive overindulgence could cause severe sickness for millions on weight loss injections. Read expert tips to stay safe this Christmas.
Firm sells illegal weight-loss drugs after MHRA raid
A company linked to a major MHRA raid continues selling unlicensed retatrutide on Telegram, posing serious health risks to UK consumers. Read the full investigation.
Medik8's At-Home Peel Delivers 'Incredible' Overnight Results
Skincare fans are raving about Medik8's Sleep Glycolic treatment, an overnight AHA peel that promises smoother, brighter skin. See the results and find it for £39.
Diabetes drugs Ozempic, Wegovy tied to chronic cough risk
A major study finds GLP-1 drugs like Ozempic increase chronic cough risk by up to 25% in type 2 diabetes patients. Discover the surprising findings and potential mechanisms behind this side effect.
Faulty Glucose Monitors Linked to Deaths, FDA Warns
The FDA warns to stop using certain Abbott FreeStyle Libre sensors after reports of 7 deaths and over 700 injuries due to incorrect low glucose readings. Check your device now.
Abbott Recalls Faulty Glucose Sensors After Deaths
Abbott issues a major recall for FreeStyle Libre 3 sensors in the UK and over a dozen countries due to inaccurate readings linked to fatalities. Millions of diabetics are urged to check their devices immediately.
Faulty Glucose Monitors Linked to 7 Deaths, FDA Warns
The FDA warns of 7 deaths and 700+ injuries linked to faulty Abbott glucose monitors. 3 million devices affected. Check your model now.
Ozempic-Style Implant Study Launched for Obese Cats
A biopharmaceutical firm is testing a long-acting GLP-1 implant in overweight cats, offering a potential six-month solution. Could this be a game-changer for pet health? Read the latest.
UK's 25% US Drug Price Deal: A 'Problematic Precedent'
The UK's agreement to pay 25% more for new US medicines has sparked warnings it could set a dangerous precedent for Australia's Pharmaceutical Benefits Scheme. Experts fear global ripple effects.
Alert Over Fake 'Godzilla' Weight-Loss Jabs Sold Online
Experts issue an urgent warning as counterfeit 'Godzilla' weight-loss injections are sold illegally online. Learn the serious health risks and safe alternatives.
Ozempic warnings: Mood and contraception risks detailed
New safety alerts for GLP-1 drugs like Ozempic link them to suicidal thoughts and reduced contraceptive efficacy. Experts advise patients on precautions.
WHO: Weight Loss Jab Shortage as Obesity to Double
The World Health Organization warns of critical shortages in GLP-1 weight loss drugs like Wegovy, with fewer than 10% who need them able to access treatment. Urgent action is needed to prevent obesity rates from soaring.
WHO: Weight Loss Jab Shortage as Obesity to Double
The World Health Organization warns fewer than 10% who need obesity drugs like Wegovy can access them. With costs soaring and supply limited, urgent action is needed to prevent a global health crisis.
UK-US agree zero tariff deal on pharmaceuticals
The UK and US have struck a deal to maintain 0% tariffs on medicines for three years, alongside NHS commitments to increase spending on new drugs. Discover the implications for patients and industry.
UK-US Agree Zero-Tariff Pharmaceuticals Deal
The UK and US have finalised a landmark trade agreement to eliminate tariffs on pharmaceutical products. Discover how this deal aims to lower drug costs and boost medical innovation.
UK and US agree zero tariff deal on medicines
The UK and US have agreed a three-year deal to maintain 0% import tariffs on pharmaceuticals, aiming to secure NHS access to cutting-edge treatments and boost investment. Read the full details.
UK-US set for zero-tariff pharma deal amid NHS price row
The UK is poised to strike a deal with the US removing tariffs on pharmaceuticals, following warnings of investment cuts. The agreement hinges on the NHS paying more for American medicines. Read the full details.
WHO: Weight loss drugs a 'new chapter' against obesity
The WHO urges global action on GLP-1 drugs like Mounjaro, calling for lower prices and wider access to tackle a crisis affecting 2 billion people by 2030. Discover the challenges and potential.
GLP-1 Weight Loss Drugs Linked to Suicidal Thoughts
Australia's TGA issues safety warning after 85 reports link Ozempic, Mounjaro & similar drugs to suicidal ideation and self-harm. Patients urged to monitor mental health.
Mental health warning for Ozempic and weight-loss drugs
Australia's medicines regulator issues new safety warnings for GLP-1 drugs like Ozempic, highlighting risks of suicidal thoughts and reduced contraceptive effectiveness. Learn the details.
Metformin reduces insulin need in type 1 diabetes
Australian clinical trial reveals metformin, an affordable century-old medication, reduces insulin requirements by 12% for type 1 diabetes patients. Discover how this breakthrough could transform diabetes management in the UK.
Best Time to Take Medication for Maximum Effect
Discover how your body clock and food intake impact medication effectiveness. Learn when to take common drugs like blood pressure pills and statins for optimal results.
Semaglutide fails to slow Alzheimer's in major trials
Groundbreaking studies show weight loss drug semaglutide does not slow cognitive decline in early Alzheimer's patients. Discover the implications for future research.
Omeprazole Warning: Medications That Don't Mix
UK health officials warn that common drugs like diazepam and warfarin may interact dangerously with omeprazole. Learn which medications to avoid and consult your GP.
The Ordinary's New Serum: A Youthful Transformation?
A beauty editor in her 40s tests The Ordinary's new volufiline serum, dubbed 'filler in a bottle'. Discover the real results on volume loss and dark circles after one month of use.
£5 Dermatologist Serum Has Women Ditching Expensive Brands
A dermatologist-designed £4.99 anti-ageing serum is revolutionising skincare, with a 50-year-old user reporting it 'completely transformed' her skin, allowing her to stop wasting money on expensive lotions.
How Ozempic is Changing Thanksgiving Traditions
As 12% of US adults use GLP-1 drugs like Ozempic, Thanksgiving meals are transforming. Discover the personal stories and expert advice navigating this new reality. Read more.
Page 1 of 11